Article info

Download PDFPDF

Original research
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma

Authors

  1. Correspondence to Dr Dipongkor Saha; Dipongkor.Saha{at}ttuhsc.edu
View Full Text

Citation

Saha D, Rabkin SD, Martuza RL
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma

Publication history

  • Accepted May 4, 2020
  • First published May 25, 2020.
Online issue publication 
May 25, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.